<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33501506</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1619-7089</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>European journal of nuclear medicine and molecular imaging</Title><ISOAbbreviation>Eur J Nucl Med Mol Imaging</ISOAbbreviation></Journal><ArticleTitle><sup>18</sup>F-FDG brain PET hypometabolism in patients with long COVID.</ArticleTitle><Pagination><StartPage>2823</StartPage><EndPage>2833</EndPage><MedlinePgn>2823-2833</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00259-021-05215-4</ELocationID><Abstract><AbstractText Label="PURPOSE">In the context of the worldwide outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), some patients report functional complaints after apparent recovery from COVID-19. This clinical presentation has been referred as "long COVID." We here present a retrospective analysis of <sup>18</sup>F-FDG brain PET of long COVID patients from the same center with a biologically confirmed diagnosis of SARS-CoV-2 infection and persistent functional complaints at least 3&#xa0;weeks after the initial infection.</AbstractText><AbstractText Label="METHODS">PET scans of 35 patients with long COVID were compared using whole-brain voxel-based analysis to a local database of 44 healthy subjects controlled for age and sex to characterize cerebral hypometabolism. The individual relevance of this metabolic profile was evaluated to classify patients and healthy subjects. Finally, the PET abnormalities were exploratory compared with the patients' characteristics and functional complaints.</AbstractText><AbstractText Label="RESULTS">In comparison to healthy subjects, patients with long COVID exhibited bilateral hypometabolism in the bilateral rectal/orbital gyrus, including the olfactory gyrus; the right temporal lobe, including the amygdala and the hippocampus, extending to the right thalamus; the bilateral pons/medulla brainstem; the bilateral cerebellum (p-voxel &lt;&#x2009;0.001 uncorrected, p-cluster &lt;&#x2009;0.05 FWE-corrected). These metabolic clusters were highly discriminant to distinguish patients and healthy subjects (100% correct classification). These clusters of hypometabolism were significantly associated with more numerous functional complaints (brainstem and cerebellar clusters), and all associated with the occurrence of certain symptoms (hyposmia/anosmia, memory/cognitive impairment, pain and insomnia) (p&#x2009;&lt;&#x2009;0.05). In a more preliminary analysis, the metabolism of the frontal cluster which included the olfactory gyrus was worse in the 7 patients treated by ACE drugs for high blood pressure (p&#x2009;=&#x2009;0.032), and better in the 3 patients that had used nasal decongestant spray at the infectious stage (p&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSION">This study demonstrates a profile of brain PET hypometabolism in long COVID patients with biologically confirmed SARS-CoV-2 and persistent functional complaints more than 3&#xa0;weeks after the initial infection symptoms, involving the olfactory gyrus and connected limbic/paralimbic regions, extended to the brainstem and the cerebellum. These hypometabolisms are associated with patients' symptoms, with a biomarker value to identify and potentially follow these patients. The hypometabolism of the frontal cluster, which included the olfactory gyrus, seems to be linked to ACE drugs in patients with high blood pressure, with also a better metabolism of this olfactory region in patients using nasal decongestant spray, suggesting a possible role of ACE receptors as an olfactory gateway for this neurotropism.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guedj</LastName><ForeName>E</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-1912-6132</Identifier><AffiliationInfo><Affiliation>APHM, CNRS, Centrale Marseille, Institut Fresnel, Timone Hospital, CERIMED, Nuclear Medicine Department, Aix-Marseille University, Marseille, France. eric.guedj@ap-hm.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campion</LastName><ForeName>J Y</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>APHM, CNRS, Centrale Marseille, Institut Fresnel, Timone Hospital, CERIMED, Nuclear Medicine Department, Aix-Marseille University, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dudouet</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>IHU-M&#xe9;diterran&#xe9;e Infection, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRD, APHM, MEPHI, Aix-Marseille University, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaphan</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>APHM, Service de Neurologie, H&#xf4;pital de la Timone, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bregeon</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>IHU-M&#xe9;diterran&#xe9;e Infection, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRD, APHM, MEPHI, Aix-Marseille University, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service des Explorations Fonctionnelles Respiratoires, CHU Nord, APHM, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tissot-Dupont</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>IHU-M&#xe9;diterran&#xe9;e Infection, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guis</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Service de Rhumatologie, H&#xf4;pital de Sainte Marguerite, AP-HM, CNRS, CRMBM-CEMEREM, UMR CNRS 7339, Aix-Marseille Universit&#xe9;, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barthelemy</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>APHM, CNRS, Centrale Marseille, Institut Fresnel, Timone Hospital, CERIMED, Nuclear Medicine Department, Aix-Marseille University, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Habert</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Radiology Department, La Timone Hospital, APHM, 264 Rue Saint Pierre, 13005, Marseille 05, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LIIE, Aix-Marseille University, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ceccaldi</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>INSERM, Inst Neurosci Syst, &amp; APHM, Service de Neurologie et de Neuropsychologie, CHU Timone, Aix-Marseille University, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Million</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IHU-M&#xe9;diterran&#xe9;e Infection, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRD, APHM, MEPHI, Aix-Marseille University, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raoult</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>IHU-M&#xe9;diterran&#xe9;e Infection, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRD, APHM, MEPHI, Aix-Marseille University, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cammilleri</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>APHM, CNRS, Centrale Marseille, Institut Fresnel, Timone Hospital, CERIMED, Nuclear Medicine Department, Aix-Marseille University, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eldin</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IHU-M&#xe9;diterran&#xe9;e Infection, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRD, AP-HM, SSA, VITROME, Aix-Marseille University, Marseille, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>07/09</GrantID><Agency>PHRC</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Nucl Med Mol Imaging</MedlineTA><NlmUniqueID>101140988</NlmUniqueID><ISSNLinking>1619-7070</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0Z5B2CJX4D</RegistryNumber><NameOfSubstance UI="D019788">Fluorodeoxyglucose F18</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2674-2675. doi: 10.1007/s00259-021-05342-y</RefSource><PMID Version="1">33813593</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019788" MajorTopicYN="Y">Fluorodeoxyglucose F18</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">18F-FDG</Keyword><Keyword MajorTopicYN="N">Angiotensin-converting&#xa0;enzyme</Keyword><Keyword MajorTopicYN="N">Anosmia</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Complaints</Keyword><Keyword MajorTopicYN="N">Dysautonomia</Keyword><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Memory</Keyword><Keyword MajorTopicYN="N">PET</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Stress</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>27</Day><Hour>5</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33501506</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pii">10.1007/s00259-021-05215-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594&#x2013;600. doi: 10.1016/j.bbi.2020.07.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Khateb M, Bosak N, Muqary M. Coronaviruses and central nervous system manifestations. Front Neurol. 2020;11:715. doi: 10.3389/fneur.2020.00715.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00715</ArticleId><ArticleId IdType="pmc">PMC7324719</ArticleId><ArticleId IdType="pubmed">32655490</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori C, Pierantozzi M, Spanetta M, Sarmati L, Cesta N, Iannetta M, et al. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain Behav Immun. 2020;88:11&#x2013;16. doi: 10.1016/j.bbi.2020.05.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.037</ArticleId><ArticleId IdType="pmc">PMC7235586</ArticleId><ArticleId IdType="pubmed">32416289</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeting the challenge of long COVID. Nat Med. 2020;26:1803. doi:10.1038/s41591-020-01177-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">33288947</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet. Facing up to long COVID. Lancet. 2020;396:1861. doi:10.1016/S0140-6736(20)32662-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834723</ArticleId><ArticleId IdType="pubmed">33308453</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano-Castro PJ, Estivill-Torr&#xfa;s G, Cabezudo-Garc&#xed;a P, Reyes-Bueno JA, Ciano Petersen N, Aguilar-Castillo MJ, et al. Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic? Neurologia. 2020;35:245&#x2013;251. doi: 10.1016/j.nrl.2020.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2020.04.002</ArticleId><ArticleId IdType="pmc">PMC7164900</ArticleId><ArticleId IdType="pubmed">32364119</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11:995&#x2013;998. doi: 10.1021/acschemneuro.0c00122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00122</ArticleId><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Million M, Dudouet P, Tissot-Dupont H, Bregeon F, Cammilleri S, et al. 18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? Eur J Nucl Med Mol Imaging. 2020;30:1&#x2013;4. doi: 10.1007/s00259-020-04973-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-04973-x</ArticleId><ArticleId IdType="pmc">PMC7391029</ArticleId><ArticleId IdType="pubmed">32728799</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Verger A, Cammilleri S. PET imaging of COVID-19: the target and the number. Eur J Nucl Med Mol Imaging. 2020;47:1636&#x2013;1637. doi: 10.1007/s00259-020-04820-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-04820-z</ArticleId><ArticleId IdType="pmc">PMC7163172</ArticleId><ArticleId IdType="pubmed">32303786</ArticleId></ArticleIdList></Reference><Reference><Citation>Morbelli S, Ekmekcioglu O, Barthel H, Albert NL, Boellaard R, Cecchin D, et al. COVID-19 and the brain: impact on nuclear medicine in neurology. Eur J Nucl Med Mol Imaging. 2020;47:2487&#x2013;2492. doi: 10.1007/s00259-020-04965-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-04965-x</ArticleId><ArticleId IdType="pmc">PMC7375837</ArticleId><ArticleId IdType="pubmed">32700058</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao X, Wang B, Kang Y. Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China. Intensive Care Med. 2020;46:357&#x2013;360. doi: 10.1007/s00134-020-05954-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05954-2</ArticleId><ArticleId IdType="pmc">PMC7042184</ArticleId><ArticleId IdType="pubmed">32025779</ArticleId></ArticleIdList></Reference><Reference><Citation>Landis BN, Leuchter I, San Mill&#xe1;n Ru&#xed;z D, Lacroix JS, Landis T. Transient hemiageusia in cerebrovascular lateral pontine lesions. J Neurol Neurosurg Psychiatry. 2006;77:680&#x2013;683. doi: 10.1136/jnnp.2005.086801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2005.086801</ArticleId><ArticleId IdType="pmc">PMC2117445</ArticleId><ArticleId IdType="pubmed">16614035</ArticleId></ArticleIdList></Reference><Reference><Citation>Mainland JD, Johnson BN, Khan R, Ivry RB, Sobel N. Olfactory impairments in patients with unilateral cerebellar lesions are selective to inputs from the contralesional nostril. J Neurosci. 2005;25:6362&#x2013;6371. doi: 10.1523/JNEUROSCI.0920-05.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0920-05.2005</ArticleId><ArticleId IdType="pmc">PMC6725278</ArticleId><ArticleId IdType="pubmed">16000626</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodranghien F, Bastian A, Casali C, Hallett M, Louis ED, Manto M, et al. Consensus paper: revisiting the symptoms and signs of cerebellar syndrome. Cerebellum. 2016;15:369&#x2013;391. doi: 10.1007/s12311-015-0687-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12311-015-0687-3</ArticleId><ArticleId IdType="pmc">PMC5565264</ArticleId><ArticleId IdType="pubmed">26105056</ArticleId></ArticleIdList></Reference><Reference><Citation>Marvel CL, Morgan OP, Kronemer SI. How the motor system integrates with working memory. Neurosci Biobehav Rev. 2019;102:184&#x2013;194. doi: 10.1016/j.neubiorev.2019.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2019.04.017</ArticleId><ArticleId IdType="pmc">PMC6604620</ArticleId><ArticleId IdType="pubmed">31039359</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsook D, Sava S, Becerra L. The pain imaging revolution: advancing pain into the 21st century. Neuroscientist. 2010;16:171&#x2013;185. doi: 10.1177/1073858409349902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858409349902</ArticleId><ArticleId IdType="pmc">PMC3370428</ArticleId><ArticleId IdType="pubmed">20400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Cammilleri S, Niboyet J, Dupont P, Vidal E, Dropinski JP, et al. Clinical correlate of brain SPECT perfusion abnormalities in fibromyalgia. J Nucl Med. 2008;49:1798&#x2013;1803. doi: 10.2967/jnumed.108.053264.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.108.053264</ArticleId><ArticleId IdType="pubmed">18927329</ArticleId></ArticleIdList></Reference><Reference><Citation>Canto CB, Onuki Y, Bruinsma B, van der Werf YD, De Zeeuw CI. The sleeping cerebellum. Trends Neurosci. 2017;40:309&#x2013;323. doi: 10.1016/j.tins.2017.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2017.03.001</ArticleId><ArticleId IdType="pubmed">28431742</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrico TJ, Abdijadid S. Neuroanatomy, Limbic System. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">30860726</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382:2268&#x2013;2270. doi: 10.1056/NEJMc2008597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimaldi S, Lagarde S, Harle JR, Boucraut J, Guedj E. Autoimmune encephalitis concomitant with SARS-CoV-2 infection: insight from 18 F-FDG PET Imaging and Neuronal Autoantibodies. J Nucl Med. 2020;61(12):1726&#x2013;1729. doi: 10.2967/jnumed.120.249292.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.120.249292</ArticleId><ArticleId IdType="pmc">PMC8679632</ArticleId><ArticleId IdType="pubmed">32709734</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18&#x2013;22. doi: 10.1016/j.bbi.2020.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611&#x2013;627. doi: 10.1016/S2215-0366(20)30203-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. 2020;87:34&#x2013;39. doi: 10.1016/j.bbi.2020.04.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.04.027</ArticleId><ArticleId IdType="pmc">PMC7152874</ArticleId><ArticleId IdType="pubmed">32298803</ArticleId></ArticleIdList></Reference><Reference><Citation>Lahav Y. Psychological distress related to COVID-19 - the contribution of continuous traumatic stress. J Affect Disord. 2020;277:12316. doi: 10.1016/j.jad.2020.07.141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2020.07.141</ArticleId><ArticleId IdType="pmc">PMC7416772</ArticleId><ArticleId IdType="pubmed">32818776</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanley B, Naresh KN, Roufosse C, Nicholson AG, Weir J, Cooke GS, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe. 2020;1:e245&#x2013;e253. 10.1016/S2666-5247(20)30115-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7440861</ArticleId><ArticleId IdType="pubmed">32844161</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Barrie M, Fuentes S, Chinot O, Mundler O. A case of cerebello-thalamo-cortical diaschisis. Clin Nucl Med. 2008;33:717&#x2013;718. doi: 10.1097/RLU.0b013e318184ba05.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RLU.0b013e318184ba05</ArticleId><ArticleId IdType="pubmed">18806580</ArticleId></ArticleIdList></Reference><Reference><Citation>Morbelli S, Drzezga A, Perneczky R, Frisoni GB, Caroli A, van Berckel BN, et al. Resting metabolic connectivity in prodromal Alzheimer&#x2019;s disease. A European Alzheimer Disease Consortium (EADC) project. Neurobiol Aging. 2012;33:2533&#x2013;2550. doi: 10.1016/j.neurobiolaging.2012.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.01.005</ArticleId><ArticleId IdType="pubmed">22365486</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Barbeau EJ, Didic M, Felician O, de Laforte C, Ranjeva JP, et al. Effects of medial temporal lobe degeneration on brain perfusion in amnestic MCI of AD type: deafferentation and functional compensation? Eur J Nucl Med Mol Imaging. 2009;36:1101&#x2013;1112. doi: 10.1007/s00259-009-1060-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-009-1060-x</ArticleId><ArticleId IdType="pubmed">19224210</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>